LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+3.52%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$781M
AUM Growth
+$781M
Cap. Flow
+$283M
Cap. Flow %
36.26%
Top 10 Hldgs %
66.38%
Holding
71
New
25
Increased
8
Reduced
8
Closed
25

Top Buys

1
ALXO icon
ALX Oncology
ALXO
$118M
2
NKTX icon
Nkarta
NKTX
$61.5M
3
KROS icon
Keros Therapeutics
KROS
$46.3M
4
GBT
Global Blood Therapeutics, Inc.
GBT
$39.4M
5
SRPT icon
Sarepta Therapeutics
SRPT
$38.6M

Top Sells

1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$31.2M
2
BNTX icon
BioNTech
BNTX
$19.7M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
$16.9M
4
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
$16.7M
5
AKBA icon
Akebia Therapeutics
AKBA
$16.3M

Sector Composition

1 Healthcare 97%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
INBX
26
DELISTED
Inhibrx, Inc. Common Stock
INBX
$5.61M 0.72%
+311,578
New +$5.61M
LSACU
27
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
$5.44M 0.7%
400,000
– –
PMVP icon
28
PMV Pharmaceuticals
PMVP
$74.2M
$5.33M 0.68%
+150,000
New +$5.33M
PAND
29
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$5.16M 0.66%
+450,000
New +$5.16M
LRMR icon
30
Larimar Therapeutics
LRMR
$310M
$5.01M 0.64%
330,000
+272,525
+474% +$4.13M
OM icon
31
Outset Medical
OM
$247M
$5M 0.64%
+100,000
New +$5M
ANNX icon
32
Annexon
ANNX
$226M
$4.83M 0.62%
+159,622
New +$4.83M
PASG icon
33
Passage Bio
PASG
$22.7M
$4.52M 0.58%
344,438
– –
RLAY icon
34
Relay Therapeutics
RLAY
$619M
$4.26M 0.55%
+100,000
New +$4.26M
KALV icon
35
KalVista Pharmaceuticals
KALV
$678M
$3.78M 0.48%
300,000
-262,900
-47% -$3.31M
BDTX icon
36
Black Diamond Therapeutics
BDTX
$157M
$3.73M 0.48%
123,465
– –
NARI
37
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.45M 0.44%
+50,000
New +$3.45M
OBIO icon
38
Orchestra BioMed
OBIO
$147M
$3.3M 0.42%
+300,000
New +$3.3M
PLRX icon
39
Pliant Therapeutics
PLRX
$101M
$3.1M 0.4%
136,715
-319,711
-70% -$7.24M
PANA.U
40
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$2.4M 0.31%
+200,000
New +$2.4M
AFIB
41
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
$2.24M 0.29%
+75,000
New +$2.24M
CHAQ.U
42
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$2.11M 0.27%
200,000
– –
TNGX icon
43
Tango Therapeutics
TNGX
$747M
$2.07M 0.27%
+200,000
New +$2.07M
FSDC
44
DELISTED
FS Development Corp. Class A Common Stock
FSDC
$1.12M 0.14%
+100,000
New +$1.12M
ARYBU
45
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$1.1M 0.14%
100,000
– –
RAPT icon
46
RAPT Therapeutics
RAPT
$188M
$1M 0.13%
31,100
-123,900
-80% -$3.99M
AKBA icon
47
Akebia Therapeutics
AKBA
$833M
– –
-1,200,000
Closed -$16.3M
APLT icon
48
Applied Therapeutics
APLT
$71M
– –
-12,600
Closed -$455K
ETNB icon
49
89bio
ETNB
$1.34B
– –
-290,000
Closed -$5.78M
FULC icon
50
Fulcrum Therapeutics
FULC
$351M
– –
-410,000
Closed -$7.5M
1
2
3